232 related articles for article (PubMed ID: 6959750)
1. Characterization of HLA-DR antigens on leukaemic cells.
Newman RA; Greaves MF
Clin Exp Immunol; 1982 Oct; 50(1):41-50. PubMed ID: 6959750
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of HLA-DR and DR-linked determinants on human leukemias and lymphoid cells.
Newman RA; Delia D; Greaves MF; Navarrete C; Fainboim L; Festenstein H
Eur J Immunol; 1983 Feb; 13(2):172-6. PubMed ID: 6187581
[TBL] [Abstract][Full Text] [Related]
3. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of two distinct light chains in HLA-DR-associated antigens by two-dimensional gel electrophoresis.
de Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
Eur J Immunol; 1982 Mar; 12(3):214-21. PubMed ID: 6178597
[TBL] [Abstract][Full Text] [Related]
5. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
Alexander S; Hubbard SC; Strominger JL
J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
Stöckbauer P; Malasková V; Soucek J; Chudomel V
Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
[TBL] [Abstract][Full Text] [Related]
7. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
Santoli D; Francis MK; Matera L; Ferrero D
J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
[TBL] [Abstract][Full Text] [Related]
8. Distribution of class IIDQ antigens on normal and leukemic lymphoid cells.
Fermand JP; Schmitt C; Brouet JC
Eur J Immunol; 1985 Dec; 15(12):1183-7. PubMed ID: 3878788
[TBL] [Abstract][Full Text] [Related]
9. Serological detection of B-cell ("Ia-like") antigens in serum of normal donor and in some sera of leukaemic patients.
Koubek K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):408-15. PubMed ID: 6182060
[TBL] [Abstract][Full Text] [Related]
10. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.
Aglietta M; Piacibello W; Stacchini A; Dezza L; Sanavio F; Malavasi F; Infelise V; Resegotti L; Gavosto F
Cancer Res; 1986 Apr; 46(4 Pt 1):1783-7. PubMed ID: 3456268
[TBL] [Abstract][Full Text] [Related]
11. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. I. Role of HLA-DR antigens as stimulatory molecules.
Matera L; Francis MK; Herlyn M; Trucco M; Santoli D
Nat Immun Cell Growth Regul; 1985; 4(2):90-102. PubMed ID: 3160934
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies against MHC class II antigens elicited with a human non-T, non-B acute lymphoblastic leukemia cell line.
Poláková K; Chorváth B; Sedlák J; Duraj J; Matoska J; Karpatová M
Neoplasma; 1985; 32(6):641-8. PubMed ID: 3911080
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
Spiro RC; Sairenji T; Humphreys RE
J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
15. Mythylation of human HLA-D/DR genes: derangement in chronic lymphocytic leukemia.
Tobe H; Ruether BA; Jerry LM; Tamaoki T
Cancer Biochem Biophys; 1986 Oct; 8(4):313-26. PubMed ID: 3492264
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the biosynthesis of HLA-DR glycoproteins in human malignant melanoma cell lines.
Lloyd KO; Ng J; Dippold WG
J Immunol; 1981 Jun; 126(6):2408-13. PubMed ID: 6785352
[TBL] [Abstract][Full Text] [Related]
17. The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement.
Melo JV; Foroni L; Brito-Babapulle V; Luzzatto L; Catovsky D
Clin Exp Immunol; 1988 Jul; 73(1):23-8. PubMed ID: 3262465
[TBL] [Abstract][Full Text] [Related]
18. Defective expression of DR antigens in chronic lymphocytic leukemia.
Cassol S; Campbell L; Hesse L; Muzik H; Ruether B; Jerry LM
Oncodev Biol Med; 1982; 3(2-3):233-49. PubMed ID: 6181487
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
20. Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules.
Wilson KM; Labeta MO; Pawelec G; Fernandez N
Immunology; 1993 Jun; 79(2):331-5. PubMed ID: 8344710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]